AB-245

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAB-245
Drug Alias NameAB-245
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAutoimmune Diseases of the Nervous SystemNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAngiocrine Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesAngiocrine Bioscience Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases of the Nervous SystemNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A